Unknown

Dataset Information

0

Characterization of Nucleoside Reverse Transcriptase Inhibitor-Associated Mutations in the RNase H Region of HIV-1 Subtype C Infected Individuals.


ABSTRACT: The South African national treatment programme includes nucleoside reverse transcriptase inhibitors (NRTIs) in both first and second line highly active antiretroviral therapy regimens. Mutations in the RNase H domain have been associated with resistance to NRTIs but primarily in HIV-1 subtype B studies. Here, we investigated the prevalence and association of RNase H mutations with NRTI resistance in sequences from HIV-1 subtype C infected individuals. RNase H sequences from 112 NRTI treated but virologically failing individuals and 28 antiretroviral therapy (ART)-naive individuals were generated and analysed. In addition, sequences from 359 subtype C ART-naive sequences were downloaded from Los Alamos database to give a total of 387 sequences from ART-naive individuals for the analysis. Fisher's exact test was used to identify mutations and Bayesian network learning was applied to identify novel NRTI resistance mutation pathways in RNase H domain. The mutations A435L, S468A, T470S, L484I, A508S, Q509L, L517I, Q524E and E529D were more prevalent in sequences from treatment-experienced compared to antiretroviral treatment naive individuals, however, only the E529D mutation remained significant after correction for multiple comparison. Our findings suggest a potential interaction between E529D and NRTI-treatment; however, site-directed mutagenesis is needed to understand the impact of this RNase H mutation.

SUBMITTER: Ngcapu S 

PROVIDER: S-EPMC5707537 | biostudies-literature | 2017 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Characterization of Nucleoside Reverse Transcriptase Inhibitor-Associated Mutations in the RNase H Region of HIV-1 Subtype C Infected Individuals.

Ngcapu Sinaye S   Theys Kristof K   Libin Pieter P   Marconi Vincent C VC   Sunpath Henry H   Ndung'u Thumbi T   Gordon Michelle L ML  

Viruses 20171108 11


The South African national treatment programme includes nucleoside reverse transcriptase inhibitors (NRTIs) in both first and second line highly active antiretroviral therapy regimens. Mutations in the RNase H domain have been associated with resistance to NRTIs but primarily in HIV-1 subtype B studies. Here, we investigated the prevalence and association of RNase H mutations with NRTI resistance in sequences from HIV-1 subtype C infected individuals. RNase H sequences from 112 NRTI treated but  ...[more]

Similar Datasets

| S-EPMC6467559 | biostudies-literature
| S-EPMC5695734 | biostudies-literature
| S-EPMC7318791 | biostudies-literature
| S-EPMC2882873 | biostudies-literature
| S-EPMC3223907 | biostudies-literature
| S-EPMC4808326 | biostudies-literature
| S-EPMC3999381 | biostudies-literature
| S-EPMC3596857 | biostudies-literature
| S-EPMC1180231 | biostudies-literature
| S-EPMC2863632 | biostudies-literature